# Interleukin-1 Blockade for the Treatment of Heart Failure in Patients With Advanced Chronic Kidney Disease

> **NCT03062176** · PHASE2 · WITHDRAWN · sponsor: **Virginia Commonwealth University**

## Conditions studied

- Heart Failure, Systolic
- Renal Disease, End Stage
- Chronic Kidney Diseases

## Interventions

- **DRUG:** Anakinra

## Key facts

- **NCT ID:** NCT03062176
- **Lead sponsor:** Virginia Commonwealth University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-04-03
- **Primary completion:** 2019-05-15
- **Final completion:** 2019-05-15
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** We screened over 200 patients but were ultimately unable to enroll anyone
- **Last updated:** 2019-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03062176

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03062176, "Interleukin-1 Blockade for the Treatment of Heart Failure in Patients With Advanced Chronic Kidney Disease". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT03062176. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*